BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27348780)

  • 1. IRF-3 gene polymorphisms are associated with the susceptibility to and the survival in chronic lymphocytic leukemia and could also serve as an auxiliary index.
    Zhang ZX; Shen CF; Shou LH; Fang Q
    Leuk Lymphoma; 2017 Mar; 58(3):646-654. PubMed ID: 27348780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
    Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
    Jamroziak K; Szemraj Z; Grzybowska-Izydorczyk O; Szemraj J; Bieniasz M; Cebula B; Giannopoulos K; Balcerczak E; Jesionek-Kupnicka D; Kowal M; Kostyra A; Calbecka M; Wawrzyniak E; Mirowski M; Kordek R; Robak T
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):945-53. PubMed ID: 19240243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia.
    Ali YB; Foad RM; Abdel-Wahed E
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3245-3250. PubMed ID: 29286214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
    Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
    Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
    Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
    Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
    Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population.
    Karabon L; Jedynak A; Tomkiewicz A; Wolowiec D; Kielbinski M; Woszczyk D; Kuliczkowski K; Frydecka I
    Folia Histochem Cytobiol; 2011; 49(1):49-54. PubMed ID: 21526489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
    Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
    Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.
    Ganster C; Neesen J; Zehetmayer S; Jäger U; Esterbauer H; Mannhalter C; Kluge B; Fonatsch C
    Genes Chromosomes Cancer; 2009 Sep; 48(9):760-7. PubMed ID: 19484764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Relevance of +936 C>T
    Ballester S; Pineda B; Rodrigues P; Tormo E; Terol MJ; Eroles P
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32585853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of MicroRNA 17-92 Cluster Host Gene (MIR17HG) Polymorphisms With Susceptibility and Prognosis for Multiple Myeloma.
    Wu H; Huang T; Ye Z; Fu X; Hu K; Yang X
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e359-e366. PubMed ID: 31029648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
    Tomatir AG; Pehlivan S; Sahin HH; Balci SO; Budeyri S; Pehlivan M
    Anticancer Res; 2015 Sep; 35(9):4807-12. PubMed ID: 26254371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia.
    Lech-Maranda E; Mlynarski W; Grzybowska-Izydorczyk O; Borowiec M; Pastorczak A; Cebula-Obrzut B; Klimkiewicz-Wojciechowska G; Wcislo M; Majewski M; Kotkowska A; Robak T; Warzocha K
    Genes Chromosomes Cancer; 2013 Mar; 52(3):287-96. PubMed ID: 23225254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different frequencies and effects of ABCB1 T3435C polymorphism on clinical and laboratory features of B cell chronic lymphocytic leukemia in Kurdish patients.
    Maroofi F; Amini S; Roshani D; Ghaderi B; Abdi M
    Tumour Biol; 2015 Apr; 36(4):2863-8. PubMed ID: 25586345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.
    Lozano-Santos C; Martinez-Velasquez J; Fernandez-Cuevas B; Polo N; Navarro B; Millan I; Garcia JM; Collado R; Sanchez-Godoy P; Carbonell F; Garcia-Vela JA; Garcia-Marco JA; Gomez-Lozano N
    PLoS One; 2014; 9(6):e101063. PubMed ID: 24971577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
    Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
    HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia.
    Zhao XQ; Cao WJ; Yang HP; Yang XW; Tang P; Sun L; Gao X
    Tumour Biol; 2016 Aug; 37(8):10393-402. PubMed ID: 26846104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.